NCT05239650 2022-05-03Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRCShanghai Henlius BiotechPhase 2 Not yet recruiting50 enrolled